SCHEMBL26830611

SCHEMBL26830611

CC1(C)O[C@H]2[C@H](c3ccc4c(N)ncnn34)O[C@]3(C#N)[C@@H](O)[C@]23O1

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.36
▸ MAP4K4 O95819 1/20 0.31
▸ PIK3CD O00329 1/20 0.31
▸ DOT1L Q8TEK3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25776745 1.00 POLRMT (0.36) POLRMTMAP4K4PIK3CDDOT1L
SCHEMBL25776452 0.85 POLRMT (0.38) POLRMTMAP4K4DOT1L
SCHEMBL23844106 0.85 POLRMT (0.37) POLRMTDOT1L
SCHEMBL26295253 0.84 — —
SCHEMBL19778891 0.84 POLRMT (0.32) POLRMT
SCHEMBL26238335 0.81 POLRMT (0.34) POLRMTDOT1L
SCHEMBL26831701 0.81 POLRMT (0.32) POLRMTPIK3CDDOT1L
SCHEMBL26827594 0.80 POLRMT (0.33) POLRMT
SCHEMBL26238413 0.80 POLRMT (0.32) POLRMTDOT1L
SCHEMBL26238443 0.80 POLRMT (0.32) POLRMTPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382940-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382940-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME EIF2AK2, MAVS, ZC3HAV1 POLRMT 13/4885MAP4K4 3760/4885PIK3CD 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback